Opko Health director granted 30,000 stock options

OPKO Health director Roger Medel received a grant of stock options covering 30,000 shares of common stock.

Rhea-AI Filing Summary

OPKO Health director Roger Medel received a grant of stock options covering 30,000 shares of common stock. The options have an exercise price of $1.42 per share, become exercisable on June 18, 2027, and expire on June 17, 2036. Following this grant, he holds 30,000 options directly.

Insider Trade Summary

Grant/Award: 30,000 shares

Grant/Award 1 txn

Insider MEDEL ROGER MD

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	30,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 30,000 contracts (Direct)

Key Figures

Options granted: 30,000 options Exercise price: $1.42 per share Exercisability date: June 18, 2027 +2 more

5 metrics

Options granted 30,000 options Grant of stock options to director Roger Medel

Exercise price $1.42 per share Exercise price for the granted stock options

Exercisability date June 18, 2027 Date options become exercisable

Expiration date June 17, 2036 Expiry of stock options grant

Options held after grant 30,000 options Total derivative securities following transaction

Key Terms

Stock Option (Right to Buy), Grant, award, or other acquisition, derivative, underlying security

4 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

derivative financial

"transaction_type: "derivative" for the stock option grant"

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

underlying security financial

"underlying_security_title: "Common Stock" as the underlying security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OPKO Health (OPK) report for Roger Medel?

OPKO Health reported that director Roger Medel received a grant of 30,000 stock options. These options give him the right to buy common shares in the future at a fixed exercise price, subject to their exercisability date and expiration.

How many OPKO Health (OPK) stock options were granted to Roger Medel?

Roger Medel was granted 30,000 stock options. Each option represents the right to purchase one share of OPKO Health common stock, giving him potential future ownership if he chooses to exercise them after they become exercisable.

What is the exercise price of Roger Medel’s OPKO Health (OPK) stock options?

The exercise price of Roger Medel’s stock options is $1.42 per share. This fixed price is what he would pay per share if he exercises the options after they become exercisable and before they expire in 2036.

When do Roger Medel’s OPKO Health (OPK) stock options become exercisable and when do they expire?

Roger Medel’s stock options become exercisable on June 18, 2027, and expire on June 17, 2036. He may only exercise the options after the exercisability date and must do so before the expiration date to acquire shares.

Does the Form 4 show open-market buying or selling by Roger Medel in OPKO Health (OPK)?

The Form 4 shows a grant of stock options to Roger Medel, not open-market buying or selling. The transaction is coded as an acquisition of derivative securities through a grant or award, rather than a purchase or sale in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 05:37 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MEDEL ROGER MD

(Last) (First) (Middle)

OPKO HEALTH, INC.

4400 BISCAYNE BLVD.

(Street)

MIAMI FLORIDA 33137

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OPKO HEALTH, INC. [ OPK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.42	06/18/2026		A		30,000		06/18/2027	06/17/2036	Common Stock	30,000	$0	30,000	D

Explanation of Responses:

	Steven D. Rubin, Attorney-in-Fact	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)